These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 37553650)

  • 41. COVID-19 pandemic control using restrictions and vaccination.
    Piccirillo V
    Math Biosci Eng; 2022 Jan; 19(2):1355-1372. PubMed ID: 35135207
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A flexible age-dependent, spatially-stratified predictive model for the spread of COVID-19, accounting for multiple viral variants and vaccines.
    Schneider KA; Tsoungui Obama HCJ; Adil Mahmoud Yousif N
    PLoS One; 2023; 18(1):e0277505. PubMed ID: 36662784
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Maintaining face mask use before and after achieving different COVID-19 vaccination coverage levels: a modelling study.
    Bartsch SM; O'Shea KJ; Chin KL; Strych U; Ferguson MC; Bottazzi ME; Wedlock PT; Cox SN; Siegmund SS; Hotez PJ; Lee BY
    Lancet Public Health; 2022 Apr; 7(4):e356-e365. PubMed ID: 35276093
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multi-Regional Modeling of Cumulative COVID-19 Cases Integrated with Environmental Forest Knowledge Estimation: A Deep Learning Ensemble Approach.
    Alamrouni A; Aslanova F; Mati S; Maccido HS; Jibril AA; Usman AG; Abba SI
    Int J Environ Res Public Health; 2022 Jan; 19(2):. PubMed ID: 35055559
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of ARIMA, ETS, NNAR, TBATS and hybrid models to forecast the second wave of COVID-19 hospitalizations in Italy.
    Perone G
    Eur J Health Econ; 2022 Aug; 23(6):917-940. PubMed ID: 34347175
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The performance of phenomenological models in providing near-term Canadian case projections in the midst of the COVID-19 pandemic: March - April, 2020.
    Smith BA; Bancej C; Fazil A; Mullah M; Yan P; Zhang S
    Epidemics; 2021 Jun; 35():100457. PubMed ID: 33857889
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nesting the SIRV model with NAR, LSTM and statistical methods to fit and predict COVID-19 epidemic trend in Africa.
    Liu XD; Wang W; Yang Y; Hou BH; Olasehinde TS; Feng N; Dong XP
    BMC Public Health; 2023 Jan; 23(1):138. PubMed ID: 36658494
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modeling and forecasting the total number of cases and deaths due to pandemic.
    Khan N; Arshad A; Azam M; Al-Marshadi AH; Aslam M
    J Med Virol; 2022 Apr; 94(4):1592-1605. PubMed ID: 34877691
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Time series prediction of under-five mortality rates for Nigeria: comparative analysis of artificial neural networks, Holt-Winters exponential smoothing and autoregressive integrated moving average models.
    Adeyinka DA; Muhajarine N
    BMC Med Res Methodol; 2020 Dec; 20(1):292. PubMed ID: 33267817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Research on COVID-19 based on ARIMA model
    Yang Q; Wang J; Ma H; Wang X
    J Infect Public Health; 2020 Oct; 13(10):1415-1418. PubMed ID: 32624404
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A deep learning approach for Spatio-Temporal forecasting of new cases and new hospital admissions of COVID-19 spread in Reggio Emilia, Northern Italy.
    Sciannameo V; Goffi A; Maffeis G; Gianfreda R; Jahier Pagliari D; Filippini T; Mancuso P; Giorgi-Rossi P; Alberto Dal Zovo L; Corbari A; Vinceti M; Berchialla P
    J Biomed Inform; 2022 Aug; 132():104132. PubMed ID: 35835438
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unraveling the dynamics of the Omicron and Delta variants of the 2019 coronavirus in the presence of vaccination, mask usage, and antiviral treatment.
    Ngonghala CN; Taboe HB; Safdar S; Gumel AB
    Appl Math Model; 2023 Feb; 114():447-465. PubMed ID: 36281307
    [TBL] [Abstract][Full Text] [Related]  

  • 53. COVID-19 prevalence forecasting using Autoregressive Integrated Moving Average (ARIMA) and Artificial Neural Networks (ANN): Case of Turkey.
    Toğa G; Atalay B; Toksari MD
    J Infect Public Health; 2021 Jul; 14(7):811-816. PubMed ID: 34118730
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictive Models for Forecasting Public Health Scenarios: Practical Experiences Applied during the First Wave of the COVID-19 Pandemic.
    Martin-Moreno JM; Alegre-Martinez A; Martin-Gorgojo V; Alfonso-Sanchez JL; Torres F; Pallares-Carratala V
    Int J Environ Res Public Health; 2022 May; 19(9):. PubMed ID: 35564940
    [No Abstract]   [Full Text] [Related]  

  • 55. SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance - Los Angeles County, California, November 7, 2021-January 8, 2022.
    Danza P; Koo TH; Haddix M; Fisher R; Traub E; OYong K; Balter S
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(5):177-181. PubMed ID: 35113851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants.
    Blanquart F; Hozé N; Cowling BJ; Débarre F; Cauchemez S
    Elife; 2022 May; 11():. PubMed ID: 35587653
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A case-case study on the effect of primary and booster immunization with China-produced COVID-19 vaccines on prevention of pneumonia and viral load among vaccinated persons infected by Delta and Omicron variants.
    Wu D; Ye Y; Tang L; Wang AB; Zhang R; Qian ZH; Wang FZ; Zheng H; Huang C; Lv XY; Wang HF; Zhang YY; Pan JJ; Li YF; Lu MX; Wang CS; Ma YT; An ZJ; Rodewald LE; Yin ZD; Wang XY; Wu ZY; Shao YM
    Emerg Microbes Infect; 2022 Dec; 11(1):1950-1958. PubMed ID: 35850623
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020-31 January 2023.
    Cegolon L; Magnano G; Negro C; Larese Filon F;
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515237
    [No Abstract]   [Full Text] [Related]  

  • 59. Application of a data-driven XGBoost model for the prediction of COVID-19 in the USA: a time-series study.
    Fang ZG; Yang SQ; Lv CX; An SY; Wu W
    BMJ Open; 2022 Jul; 12(7):e056685. PubMed ID: 35777884
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative complete scheme and booster effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infections with SARS-CoV-2 Omicron (BA.1) and Delta (B.1.617.2) variants: A case-case study based on electronic health records.
    Kislaya I; Peralta-Santos A; Borges V; Vieira L; Sousa C; Ferreira B; Pelerito A; Gomes JP; Leite PP; Nunes B; ; Machado A; Rodrigues AP; Peixoto VR; Casaca P; Fernandes E; Rodrigues E; Ferreira R; Isidro J; Pinto M; Duarte S; Santos D; Meneses L; Almeida JP; Matias A; Freire S; Grilo T
    Influenza Other Respir Viruses; 2023 Mar; 17(3):e13121. PubMed ID: 36935845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.